Freezing

IceCure Medical Reports Positive Topline Results From ICE3 Cryoablation Breast Cancer Study: Achievement of 96.39% Recurrence Free Rate Brings Company One Step Closer to Providing Women a Non-Surgical Alternative to Lumpectomy

Retrieved on: 
Tuesday, March 19, 2024
Classification, Patient, Neoplasm, LN2, Freezing, Marketing, Woman, Safety, ICE3, FDA, Food

In the ICE3 study, 96.39% of patients (187 out of 194 patients) were local recurrence-free with no significant device-related adverse events or complications reported.

Key Points: 
  • In the ICE3 study, 96.39% of patients (187 out of 194 patients) were local recurrence-free with no significant device-related adverse events or complications reported.
  • Based on the strength of the topline results, ProSense has the potential to be a safe and effective alternative to lumpectomy for early-stage breast cancer.
  • "We are very pleased with this topline outcome and believe these results demonstrate a highly favorable safety and efficacy profile that positions ProSense® as a desirable alternative to lumpectomy for early-stage breast cancer.
  • "On behalf of the entire IceCure team, I thank the patients, their families, the sites and the clinicians for taking part in this landmark study.

Pioneering industrial refrigeration engineer, Dr Forbes Pearson, dies at 92

Retrieved on: 
Monday, March 18, 2024
Butter, Technical director, Learning, Pleurisy, Stroke, Kelvinside Academy, Child, Infant, Branch, Church, Carbon, Love, BSI, Research, Mechanical, Science, Montreal Protocol, Chlorofluorocarbon, Village hall, Nobel Prize, Computer, Rolls-Royce, Freezing, Language, Yacht, Precocious, Electricity, Christianity, Associate, Coffee, Commander, Knowledge, University, Crusader, Student, Family, Engineering, Temperature, Growth, CSSM, Wellington Church, Parish church, Doctor of Philosophy, R-12, Life, CFC, Organic, Central Science Laboratory, Multimedia, Royal college, Tecumseh Products, Tourism

GLASGOW, Scotland, March 18, 2024 /PRNewswire-PRWeb/ -- Stephen Forbes Pearson was the first child of Stephen H Pearson, an engineer from Northumberland, and Gladys Stewart, from Glasgow. Forbes was born in Pollokshields, Glasgow, on 25 June 1931 and attended school at Paisley Grammar and then Kelvinside Academy. He was a precocious child who loved learning and absorbed facts easily, particularly about the natural sciences. In infant school, he was reprimanded for arguing with a teacher who had told the class that the earth was a sphere. "No, it's an oblate spheroid" he said. Despite a bout of pleurisy as a teenager that required a lengthy recuperation, he enjoyed playing rugby as a front row forward, where he reckoned his short legs and stocky body gave him a particular mechanical advantage.

Key Points: 
  • Forbes was born in Pollokshields, Glasgow, on 25 June 1931 and attended school at Paisley Grammar and then Kelvinside Academy.
  • He spent undergraduate summer vacations working in the Rolls Royce factory at Hillington and the Tecumseh compressor factory in Michigan.
  • They also shared a love of language and a rather coarse sense of humour that sometimes took others by surprise.
  • As Chief Engineer for Sterne his work was divided between design of products, such as industrial compressors and heat exchangers, and design of industrial refrigeration systems.

Methodist Le Bonheur Healthcare first in Tennessee to offer "paradigm-shifting" technology for AFib patients

Retrieved on: 
Thursday, March 14, 2024
MLH, Le Bonheur Children's Hospital, Heat, Atrial fibrillation, Anesthesia, Patient, Methodist University Hospital, PFA, Medtronic, Freezing, Arrhythmia, Ventricular fibrillation, Methodism, Cardiac electrophysiology, Hospital

MEMPHIS, Tenn. , March 14, 2024 /PRNewswire/ -- Methodist Le Bonheur Healthcare is proud to announce it is the first healthcare system in Tennessee to offer the Medtronic PulseSelect™ Pulsed Field Ablation (PFA) technology to patients suffering from atrial fibrillation (AF).

Key Points: 
  • MEMPHIS, Tenn. , March 14, 2024 /PRNewswire/ -- Methodist Le Bonheur Healthcare is proud to announce it is the first healthcare system in Tennessee to offer the Medtronic PulseSelect™ Pulsed Field Ablation (PFA) technology to patients suffering from atrial fibrillation (AF).
  • "Pulsed Field Ablation is a paradigm-shifting technology," said Dr. Yehoshua Levine, division chief of cardiac electrophysiology at Methodist Le Bonheur Healthcare who performed the first PFA at Methodist University Hospital.
  • "PFA allows us to deliver timely treatment to more patients when they need help the most," said Dr. James Litzow, cardiac electrophysiologist with Methodist Le Bonheur Germantown Hospital.
  • Across the MLH system , the cardiovascular team at Methodist University Hospital conducted the first PFA for the healthcare system on March 11 with Methodist Le Bonheur Germantown Hospital's cardiovascular team conducting its first PFA on March 12.

IceCure Receives Notice of Patent Allowance in Japan for a Novel Cryogen Flow Control to Optimize Patient Outcomes

Retrieved on: 
Tuesday, March 12, 2024
Temperature, JPO, Partnership, Anatomy, Neoplasm, Freezing, IP, Patent, Catheter

A patent for this invention is pending approval in European Union, the U.S., and other major markets.

Key Points: 
  • A patent for this invention is pending approval in European Union, the U.S., and other major markets.
  • Cryogenic flow control achieves this by utilizing sensor data to regulate the flow of cryogens, ensuring the desired temperature is reached and maintained at the distal tip of catheters and probes.
  • Advanced cryogen flow control systems may also offer functionalities, such as navigation and mapping support within the patient's anatomy, and be incorporated into a wide range of cryosurgical tools.
  • This Notice of Allowance in Japan further fortifies our position in an important market, served in partnership with our in-country distributor, Terumo."

Why there may be oceans inside dwarf planets beyond Pluto – and what this means for the likely abundance of life

Retrieved on: 
Friday, April 5, 2024
Neutron, Solar System, Sun, Solar, Isotope, Conference, Mariner 2, Research, Cassini, Spacecraft, Life, Thought, Freezing, Chemistry, System, Vent pecking, Water, Ice, Enceladus, Hot, Lip, Sulfur

In fact, icy moons and dwarf planets in the outer Solar System appear to have liquid oceans below layers of thick ice.

Key Points: 
  • In fact, icy moons and dwarf planets in the outer Solar System appear to have liquid oceans below layers of thick ice.
  • Recent research suggests there could even be oceans inside bodies beyond Pluto.

Tidal heating

  • Io therefore overtakes Europa after every two orbits, receiving a regularly repeated tidal tug from Europa that prevents Io’s orbit from becoming circular.
  • Peale’s prediction of tidal heating was vindicated only a week after publication when Voyager-1, the the first sophisticated flyby of Jupiter, sent back images of volcanoes erupting on Io.
  • This isn’t likely to be due to tidal heating but instead possibly down to heat given off by decay of radioactive elements.
  • Saturn has a relatively small (504km radius) icy moon called Enceladus, which has an internal ocean thanks to tidal heating from interaction with the larger moon called Dione.

Other oceans

  • Puzzlingly, even for moons that should have no tidal heating, and for bodies that aren’t moons at all, evidence for internal oceans keeps mounting up.
  • The authors suggest that heat from the decay of radioactive elements in the rock is sufficient to explain how these internal oceans have been kept warm enough to avoid freezing.
  • It is possible that other underground oceans could be similarly inhospitable.
  • David Rothery is co-leader of the European Space Agency's Mercury Surface and Composition Working Group, and a Co-Investigator on MIXS (Mercury Imaging X-ray Spectrometer) that is now on its way to Mercury on board the European Space Agency's Mercury orbiter BepiColombo.
  • He is author of Planet Mercury - from Pale Pink Dot to Dynamic World, Moons: A Very Short Introduction and Planets: A Very Short Introduction.

BLUETTI to Showcase Innovative Energy Solutions at Smart Energy Expo 2024 in Australia

Retrieved on: 
Tuesday, March 5, 2024
International Convention Centre Sydney, Smart Energy, Temperature, Freezing, Refrigeration, Drink, Ecosystem, Coffee, B70, Electric battery

SYDNEY, AU, Mar 5, 2024 - (ACN Newswire) - BLUETTI, a leading provider of portable power solutions, will be participating in the Smart Energy Expo 2024 at ICC Sydney from March 6-7.

Key Points: 
  • SYDNEY, AU, Mar 5, 2024 - (ACN Newswire) - BLUETTI, a leading provider of portable power solutions, will be participating in the Smart Energy Expo 2024 at ICC Sydney from March 6-7.
  • At booth #33, BLUETTI will present its revolutionary energy solutions that are shaping the smart energy landscape.
  • The AC180T power station delivers 1,800W power for essential devices from coffee makers to portable air conditioners.
  • Visit BLUETTI at booth #33 to experience firsthand the future of portable power solutions.

BLUETTI Launches SwapSolar on Indiegogo, Elevating Your Outdoor Experience

Retrieved on: 
Thursday, February 22, 2024
Emergency, USD, Temperature, ECO, Freezing, Refrigeration, LFP, System, Ice, Camping, Lifting, Ecosystem, AEDT, Policy, CES, B70, LCD, Environment, AC, Electric battery

The SwapSolar is not just a product; it's an answer to your outdoor power needs, ice-making desires, and long-distance travel cooling cravings - all in one.

Key Points: 
  • The SwapSolar is not just a product; it's an answer to your outdoor power needs, ice-making desires, and long-distance travel cooling cravings - all in one.
  • The AC180T ensures your independent outdoor power supply off the grid, while the MultiCooler's 3-in-1 design provides excellent coolness and efficiency.
  • As BLUETTI's spokesperson, James Ray, aptly puts it, "We want users to savor the joy of outdoor life.
  • Power up and keep your food fresh at once, it's time to go wild with BLUETTI!"

Concrete Pumping Holdings Reports First Quarter Fiscal Year 2024 Results

Retrieved on: 
Thursday, March 7, 2024
Weather, CPH, Share repurchase, Growth, Freezing, Adjustment, Annual report, Standstill, Waste management, GAAP, Public expenditure, Snow, G&A, BBCP, Insurance, Video game

First Quarter Fiscal Year 2024 Summary vs. First Quarter of Fiscal Year 2023 (unless otherwise noted)

Key Points: 
  • First Quarter Fiscal Year 2024 Summary vs. First Quarter of Fiscal Year 2023 (unless otherwise noted)
    Revenue increased 4% to $97.7 million compared to $93.6 million.
  • Revenue in the first quarter of fiscal year 2024 increased 4% to $97.7 million compared to $93.6 million in the first quarter of fiscal year 2023.
  • Revenue in the first quarter of fiscal 2024 decreased 0.8% to $66.7 million compared to $67.2 million in the prior year quarter.
  • Net income in the first quarter of fiscal year 2024 was $2.4 million compared to $2.8 million in the prior year quarter.

HRC Fertility Announces Dream Plus Embryo Banking Package

Retrieved on: 
Thursday, March 7, 2024
Women, Parenting, Children, Baby, Maternity, LGBTQ+, Men, Family, General Health, Consumer, Health, Fertility, IVF, HRC, Woman, Ovarian reserve, Freezing, Patient, Birth control

HRC Fertility (HRC), one of the largest and established providers of advanced fertility treatments, is proud to introduce its latest offering, the Dream Plus Embryo Banking package , in anticipation of National Infertility Awareness Week , April 21-27.

Key Points: 
  • HRC Fertility (HRC), one of the largest and established providers of advanced fertility treatments, is proud to introduce its latest offering, the Dream Plus Embryo Banking package , in anticipation of National Infertility Awareness Week , April 21-27.
  • “We are thrilled to launch the Dream Plus package, particularly as we head toward National Infertility Awareness Week,” said Sherif Hanna, CEO at HRC Fertility.
  • With the Dream Plus Embryo Banking package, we aim to alleviate some challenges associated with multiple stimulation cycles, especially for those with lower ovarian reserve or advanced reproductive age.”
    As part of the Dream Plus Embryo Banking package, patients will benefit from embryo freezing with one year of included storage, subject to limitations and exclusions.
  • To learn more about HRC Fertility and its Dream Plus Embryo Banking Package or book an appointment, please visit https://www.havingbabies.com/appointments/ .

S.BIOMEDICS completes brain transplant of hESC-derived dopaminergic progenitors (TED-A9) for Phase 1/2a study in patients with Parkinson’s disease

Retrieved on: 
Thursday, February 29, 2024
Stem Cells, Data Management, Biotechnology, Technology, Health, Neurology, Research, Hospitals, Surgery, Science, Clinical Trials, Severance Hospital, Dyskinesia, KOSDAQ, Safety, Neuron, Yonsei University, DLT, Freezing, Cell, Parkinson's disease, Transplant, Putamen, Patient, Clinical trial, Gait, Brain, Pharmaceutical industry

S.BIOMEDICS Co., Ltd. (KOSDAQ: 304360) announced that it has successfully completed the brain transplant of TED-A9 (hESC-derived dopaminergic progenitors) for Phase 1/2a study for treating Parkinson's disease.

Key Points: 
  • S.BIOMEDICS Co., Ltd. (KOSDAQ: 304360) announced that it has successfully completed the brain transplant of TED-A9 (hESC-derived dopaminergic progenitors) for Phase 1/2a study for treating Parkinson's disease.
  • The primary objective of the Phase 1/2a trial is to assess the safety and exploratory efficacy of TED-A9 transplantation for two years post-transplant.
  • “We have developed a fundamental therapeutic mechanism that directly replaces dopaminergic neurons lost in patients with Parkinson's disease.
  • TED-A9 could represent a fundamental treatment that surpasses current therapies, which only temporarily alleviate the symptoms of Parkinson’s disease,” he added.